 Biomerica NASDAQ: BMRA is one of 27 publicly-traded companies in the Diagnostic substances industry, but how does it compare to its peers? We will compare Biomerica to related businesses based on the strength of its dividends, risk, valuation, analyst recommendations, earnings, profitability and institutional ownership. Risk Volatility Biomerica has a beta of -0.9, suggesting ... 